reports
Sunic System Ltd: 1 director
A director at Sunic System Ltd sold 4,000 shares at 56,300.000KRW and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Okeanis Eco Tankers Corp. – Announcement of Availability of 2023 Annua...
Okeanis Eco Tankers Corp. – Announcement of Availability of 2023 Annual Report on Form 20-F ATHENS, Greece, April 30, 2024 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “SEC”). The Annual Report may be downloaded from the SEC’s website () and is also available under the Investor Relations section (Financial Reports and Webcasts) of the Company’s website (). H...
FANHUA Files Annual Report on Form 20-F on April 29, 2024 and Announce...
FANHUA Files Annual Report on Form 20-F on April 29, 2024 and Announces Adoption of Semi-annual Financial Results Reporting Schedule GUANGZHOU, China, April 30, 2024 (GLOBE NEWSWIRE) -- FANHUA Inc. (Nasdaq: ) (the “Company” or “FANHUA”), a leading independent technology-driven financial services provider in China, today announced that it has filed its 2023 annual report on Form 20-F (the “2023 20-F”), which contains its audited financial statements for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (the “SEC”) on April 29, 2024. The 2023 20-F can...
Resolutions of Annual General Meeting of Shareholders
Resolutions of Annual General Meeting of Shareholders The following resolutions have been adopted at the Annual General Meeting of Shareholders of Panevezio statybos trestas AB held on 30 April 2024: 1. Presentation of the Independent Auditor’s Report. Information heard. 2. Consolidated Annual Report of Panevezio statybos trestas AB for the year 2023. The Consolidated Annual Report of Panevezio statybos trestas AB for the year 2023 approved by the Board heard. 3. Approval of the set of Financial Statements of Panevezio statybos trestas AB for the year 2023 and the set of Financial Stat...
Eilinio visuotino akcininkų susirinkimo priimti nutarimai
Eilinio visuotino akcininkų susirinkimo priimti nutarimai 2024 m. balandžio 30 d. įvykusio AB „Panevėžio statybos trestas“ eilinio akcininkų susirinkimo priimti nutarimai: 1. Dėl nepriklausomų auditorių išvados pristatymo. Informacija išklausyta. 2. Dėl AB „Panevėžio statybos trestas“ konsoliduotojo 2023 m. metinio pranešimo. Išklausytas valdybos patvirtintas AB „Panevėžio statybos trestas“ 2023 m. konsoliduotas metinis pranešimas 3. Dėl AB „Panevėžio statybos trestas“ 2023 metų finansinių ataskaitų rinkinio ir AB „Panevėžio statybos trestas“ įmonių grupės 2023 metų finansinių ataskait...
- Jean Danjou
- Oliver Metzger
ODDO BHF Small & MIDCAP MORNING NEWS - 30/04/2024 Date Performance dep...
L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) vs Au...
CRI CHARGEURS SA
VCT VICAT-CIMENTS VICAT SA
FLY SOCIETE FONCIERE LYONNAISE SA
TYRES NOKIAN RENKAAT OYJ
VETO VETOQUINOL SA
BAMNB KONINKLIJKE BAM GROEP NV
BIG BIGBEN INTERACTIVE SA
GMM GRAMMER AG
FIE FIELMANN AG
DEZ DEUTZ AG
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
ARCAD ARCADIS NV
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
ROYAL VOPAK NV
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
FTG111 FLATEXDEGIRO AG
UNI UNICAJA BANCO S.A.
MOR MORPHOSYS AG
NFN NFON AG
WAVE WAVESTONE SA
NACON NACON SASU
ALHRS HYDROGEN REFUELING SOLUTIONS
ANTIN ANTIN INFRASTRUCTURE PARTNERS
FPE3 FUCHS PETROLUB SE
EXN EXCLUSIVE NETWORKS SA
WAGA WAGA ENERGY SA
- Jean Danjou
- Oliver Metzger
ODDO BHF Small & MIDCAP MORNING NEWS - 04/30/2024
BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - ...
CRI CHARGEURS SA
VCT VICAT-CIMENTS VICAT SA
FLY SOCIETE FONCIERE LYONNAISE SA
TYRES NOKIAN RENKAAT OYJ
VETO VETOQUINOL SA
BAMNB KONINKLIJKE BAM GROEP NV
BIG BIGBEN INTERACTIVE SA
GMM GRAMMER AG
FIE FIELMANN AG
DEZ DEUTZ AG
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
ARCAD ARCADIS NV
FCC FOMENTO DE CONSTRUCCIONES Y CONTRATAS S.A.
ROYAL VOPAK NV
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
FTG111 FLATEXDEGIRO AG
UNI UNICAJA BANCO S.A.
MOR MORPHOSYS AG
NFN NFON AG
WAVE WAVESTONE SA
NACON NACON SASU
ALHRS HYDROGEN REFUELING SOLUTIONS
ANTIN ANTIN INFRASTRUCTURE PARTNERS
FPE3 FUCHS PETROLUB SE
EXN EXCLUSIVE NETWORKS SA
WAGA WAGA ENERGY SA
Li Auto Inc. Announces Completion of the Put Right Offer for Its 0.25%...
Li Auto Inc. Announces Completion of the Put Right Offer for Its 0.25% Convertible Senior Notes due 2028 BEIJING, China, April 30, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it has completed its previously announced put right offer relating to its 0.25% Convertible Senior Notes due 2028 (CUSIP No. 50202M AB8) (the “Notes”). The put right offer expired at 5:00 p.m., New York City time, on Monday, April 29, 2024. Based on the information from Deutsche Bank Trust Company Ame...
EQS-News: New ISG study: q.beyond confirmed as Microsoft Leader
EQS-News: q.beyond AG / Key word(s): Study New ISG study: q.beyond confirmed as Microsoft Leader 30.04.2024 / 12:00 CET/CEST The issuer is solely responsible for the content of this announcement. New ISG study: q.beyond confirmed as Microsoft Leader q.beyond is once more a “Leader” in “Microsoft 365 Services - Midmarket” and “SAP on Azure Services” It is also a “Rising Star” for the first time for “Power Platform Services” and “Generative AI Services for the Microsoft Clouds” Combination of consulting and operations expertise pays off Cologne, 30 April 2024 – In the n...
EQS-News: Neue Studie von ISG: q.beyond als Microsoft-Leader bestätigt
EQS-News: q.beyond AG / Schlagwort(e): Studie Neue Studie von ISG: q.beyond als Microsoft-Leader bestätigt 30.04.2024 / 12:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Neue Studie von ISG: q.beyond als Microsoft-Leader bestätigt q.beyond ist erneut „Leader“ bei „Microsoft 365 Services Mittelstand“ und „SAP on Azure Services“ Erstmals „Rising Star“ bei „Power Platform Services“ und „Generative AI Services for the Microsoft Clouds“ Kombination aus Beratungs- und Betriebs-Know-how zahlt sich aus Köln, 30. April 2024 – Im neuen ...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in New...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase 2 clinical trial evaluating INB-400 in patients with newly diagnosed glioblastoma multiforme (GBM) has been successfully dosed at the Cleveland Clinic in Ohio. INB-400 is the Company’s first autologous gamma-delta T cell therapy product candidate genetically engineered to survive chem...
Man Group PLC : Form 8.3 - Barratt Developments plc
Man Group PLC : Form 8.3 - Barratt Developments plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant secur...
- Paolo Pizzoli
Italian GDP growth accelerates in the first quarter
Domestic demand acted as a drag while net exports drove growth. As temporary factors might have helped in the first quarter, we cannot rule out a slight softening of growth in the second. Still, Italy seems to have survived the restrictive monetary policy of the European Central Bank relatively well
Oaktree Specialty Lending Corporation Announces Permanent Base Managem...
Oaktree Specialty Lending Corporation Announces Permanent Base Management Fee Reduction LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ:OCSL) (“OCSL” or the “Company”) today announced a permanent reduction in its base management fee. Effective July 1, 2024, the base management fee will be reduced to an annual rate of 1.00% from 1.50% on gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents. The new base management fee will be calculated net of the base management fees that Oaktree Fund Advise...
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics to Present at Upcoming Conferences SAN CARLOS, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conferences: Chardan Annual Genetic Medicines & Cell Therapy Manufacturing Summit Fireside Chat: April 30, 2024 at 2:30 p.m. ETVirtual The Citizens JMP Life Sciences ConferenceFireside Chat: Ma...
Man Group PLC : Form 8.3 - Tyman plc
Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
Crawford United Corporation Announces First Quarter 2024 Results
Crawford United Corporation Announces First Quarter 2024 Results Sales of $38.4 million for the quarter$4.6 million sequential increase in sales from prior quarterNet income of $3.0 million Earnings per share of $0.85 EBITDA As Defined1 of $6.7 million CLEVELAND, April 30, 2024 (GLOBE NEWSWIRE) -- Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the quarter ended March 31, 2024. For the quarter ended March 31, 2024, sales were $38.4 million compared with $39.5 million in the same period in 2023, a decre...
- ABGSC Financials Research
- Jan Erik Gjerland
- Magnus Andersson
- Patrik Brattelius
H World Group Limited Announces Completion of the Put Right Offer for ...
H World Group Limited Announces Completion of the Put Right Offer for Its 3.00% Convertible Senior Notes due 2026 SHANGHAI, China, April 30, 2024 (GLOBE NEWSWIRE) -- H World Group Limited (Nasdaq: HTHT and HKEx: 1179, the “Company” or “H World”), a key player in the global hotel industry, today announced that it has completed its previously announced put right offer relating to its 3.00% Convertible Senior Notes due 2026 (CUSIP No. 44332NAB2) (the “Notes”). The put right offer expired at 5:00 p.m., New York City time, on Monday, April 29, 2024. Based on information from Wilmington Trust, ...
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Announces Participation in Upcoming Investor Conferences VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management will participate in one-on-one meetings on May 15th in Las Vegas, NV.J.P. Morgan Biote...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.